SCHEMBL7197831

SCHEMBL7197831

O=C(CCl)Nc1cc[c]cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.58
RAB9A P51151 3/20 0.58
MITF O75030 3/20 0.58
XBP1 P17861 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
NOD2 Q9HC29 1/20 0.58
ALDH1A1 P00352 10/20 0.56
SMN1; SMN2 Q16637 8/20 0.56
HTT P42858 7/20 0.56
PRMT1 Q99873 1/20 0.56
MAPT P10636 6/20 0.51
LMNA P02545 4/20 0.51
KMT2A Q03164 4/20 0.51
KDM4E B2RXH2 2/20 0.51
MEN1 O00255 2/20 0.51
RNF4 P78317 1/20 0.51
CASP3 P42574 1/20 0.47
CASP2 P42575 1/20 0.47
HPGD P15428 2/20 0.45
OPRM1 P35372 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9081388 0.84 NPC1 (0.76) NPC1RAB9AMITFXBP1NPSR1
SCHEMBL7648450 0.84 TP53 (0.47) NPC1RAB9AMITFXBP1NPSR1
SCHEMBL7648464 0.81 ALDH1A1 (0.47) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL196368 0.81 MEN1 (0.42) NPC1RAB9AMITFXBP1NPSR1
SCHEMBL7649688 0.80 HDAC1 (0.49) ALDH1A1KMT2AKDM4EMEN1POLB
SCHEMBL7648257 0.79 MEN1 (0.41) NPC1RAB9AMITFXBP1NPSR1
SCHEMBL7653980 0.79 MEN1 (0.41) NPC1RAB9AMITFXBP1NPSR1
SCHEMBL6966256 0.79 MEN1 (0.50) MAPTKMT2AMEN1POLBL3MBTL1
SCHEMBL7648767 0.79 MEN1 (0.45) NPC1RAB9AMITFXBP1NPSR1
SCHEMBL1356630 0.79 CA1 (0.55) LMNAKMT2AMEN1POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002536440-A 2002-10-29 JP claimed
EP-1155007-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. Searle LLC (US) 2001-11-21 EP claimed
WO-2000047568-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. SEARLE LLC (US) 2000-08-17 WO claimed
EP-0095640-B1 ALKYLENE-BRIDGED GUANIDINO-THIAZOLE DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS BAYER AG (DE) 1986-01-29 EP claimed
US-6566355-B1 Useful in combination with beta -lactam antibiotics in the control of beta -lactamase forming pathogens HOFFMANN-LA ROCHE INC. 2003-05-20 US disclosed
EP-1155007-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. Searle LLC (US) 2001-11-21 EP disclosed
US-6218379-B1 Tricyclic carbacephems HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
WO-2000047568-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. SEARLE LLC (US) 2000-08-17 WO disclosed
EP-0912574-A1 BETA-LACTAMS F. HOFFMANN-LA ROCHE AG (CH) 1999-05-06 EP disclosed
US-5712268-A Compositions of tricyclic β-lactams and uses thereof HOFFMANN-LA ROCHE INC. (US) 1998-01-27 US disclosed
US-5698577-A ANTIBIOTICS HOFFMANN-LA ROCHE INC. (US) 1997-12-16 US disclosed
WO-1997045429-A1 BETA-LACTAMS F. HOFFMANN-LA ROCHE AG (CH) 1997-12-04 WO disclosed
EP-0508234-B1 Beta-lactames HOFFMANN LA ROCHE (CH) 1996-07-24 EP disclosed
US-5510343-A BETA-LACTAMASE INHIBITOR HOFFMANN-LA ROCHE INC. (US) 1996-04-23 US disclosed
US-5494666-A BETA-LACTAMASE INHIBITORS, ANTIBACTERIALS HOFFMANN-LA ROCHE INC. (US) 1996-02-27 US disclosed
US-5464617-A 1H-2,6a-diazacyclobut(cd)indene-6-carboxylic acid derivatives, antibiotics HOFFMANN-LA ROCHE INC. (US) 1995-11-07 US disclosed
EP-0671401-A1 Beta lactames F. HOFFMANN-LA ROCHE AG (CH) 1995-09-13 EP disclosed
EP-0508234-A2 Beta-lactames F. HOFFMANN-LA ROCHE AG (CH) 1992-10-14 EP disclosed
EP-0095640-B1 ALKYLENE-BRIDGED GUANIDINO-THIAZOLE DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS BAYER AG (DE) 1986-01-29 EP disclosed